Clik here to view.
pSivida Corp. Reports FDA Labeling Discussions for ILUVIEN® for DME; Advisory...
WATERTOWN, Mass. pSivida Corp. (NASDAQ: PSDV) (ASX: PVA), a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that its licensee...
View ArticleClik here to view.
Blaze Bioscience Announces Initiation of First-in-Human Phase 1 Clinical...
SEATTLE & MELBOURNE, Australia Blaze Bioscience, Inc. and its subsidiary, Blaze Bioscience Australia Pty Ltd, today announced the initiation of the first Phase 1 clinical study of the first...
View ArticleClik here to view.
United Health Products Inc. Receives Initial HemoStyp® Order for Australian...
WESTBURY, N.Y. United Health Products, Inc. (OTCQB:UEEC) announced that its Australian distributor, Critical Health Products Ltd., has placed an initial order for HemoStyp® gauze products. The order...
View ArticleClik here to view.
World’s First MEVION S250 Proton Therapy Treatment Delivered at Barnes-Jewish...
Smart Multimedia Gallery View of the MEVION S250 Proton Therapy System treatment room at the Siteman Cancer Center at Barnes-Jewish Hospital in St. Louis, MO. (Photo: Business Wire) View and Share...
View ArticleClik here to view.
Clik here to view.
CARMAT的生物假体人工心脏首次植入人体
巴黎 (美国商业资讯) –CARMAT (Paris:ALCAR) (FR0010907956, ALCAR)是世界上最先进的全人工心脏课题的设计者和开发者, 为罹患终末期心力衰竭的人士提供另一种医疗选择。该公司宣布，依据ANSM（法国卫生部国家药品及保健产品安全署）和个人保护委员会（伦理委员会）颁发的批复，公司的人工心脏已在一项可行性研究中首次植入人体。...
View ArticleClik here to view.
世界初のMEVION S250による陽子線治療をバーンズ・ジューイッシュ病院で実施
Smart Multimedia Gallery View of the MEVION S250 Proton Therapy System treatment room at the Siteman Cancer Center at Barnes-Jewish Hospital in St. Louis, MO. (Photo: Business Wire) View and Share...
View ArticleClik here to view.
カルマトのバイオプロテーゼ人工心臓を初めてヒトに移植
パリ （ビジネスワイヤ） — 世界最先端の完全人工心臓プロジェクトを設計・開発し、末期心不全を患う人々に代替法を提供しているカルマト（Paris:ALCAR）（FR0010907956,...
View ArticleClik here to view.
GE收购Thermo Fisher Scientific战略性资产，扩大生命科学业务
英格兰CHALFONT ST. GILES –(美国商业资讯)–GE (NYSE:GE)与Thermo Fisher Scientific (NYSE:TMO)今天宣布达成一项协议，由GE医疗集团以近10.6亿美元的价格收购Thermo Fisher的HyClone™...
View ArticleClik here to view.
Navidea Biopharmaceuticals Expands Lymphoseek® Global Commercialization Efforts
DUBLIN, Ohio Navidea Biopharmaceuticals, Inc. (NYSE MKT:NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, announced today it has entered into a distribution...
View ArticleClik here to view.
Allergan, Inc. and Medytox, Inc. Complete Licensing Agreement
IRVINE, Calif. & SEOUL, South Korea Allergan, Inc., (NYSE: AGN) and Medytox, Inc. today announced that they have closed the license agreement which was previously announced on September 25,...
View ArticleClik here to view.
Clik here to view.
Nordson to Demonstrate Manufacturing Line Solution Technologies for...
CARLSBAD, Calif. Nordson Corporation (NASDAQ: NDSN) announces that its Advanced Technology Systems’ operation in Japan will be exhibiting new products and technologies for precision fluid...
View ArticleClik here to view.
STENTYS Expands Marketing of its Stents in Asia
PRINCETON, N.J. & PARIS STENTYS (FR0010949404 – STNT), a medical technology company commercializing the world’s first and only Self-Apposing® Stent for treating acute myocardial infarction...
View ArticleClik here to view.
MicroPort Scientific Corporation and Sorin Group Sign Joint Venture Agreement...
SHANGHAI & MILAN MicroPort Scientific Corporation (HK: 00853) and Sorin Group (MIL:SRN) (Reuters Code: SORN.MI), announced today that they have entered into a definitive agreement to form a...
View ArticleClik here to view.
有关KCI负压伤口滴注疗法的首篇国际共识指南发表
圣安东尼奥 (美国商业资讯)–Kinetic Concepts, Inc. (KCI)今天宣布，有关该公司负压伤口滴注疗法(NPWTi)的首篇国际共识指南发表。 1 该指南发表于《整形及整复外科杂志》12月刊上。 KCI首席医学官Ron...
View ArticleClik here to view.
Akorn Acquires Betimol® from Santen
LAKE FOREST, Ill. Akorn, Inc. (NASDAQ: AKRX), a niche generic pharmaceutical company, today announced that it has acquired the NDA and all rights to Betimol® (timolol ophthalmic solution) 0.25%...
View ArticleClik here to view.
KCIの洗浄併用陰圧創傷治療に関し、初の国際コンセンサスガイドラインが公刊される
サンアントニオ （ビジネスワイヤ） — キネティック・コンセプツ（KCI）は本日、当社の洗浄併用陰圧創傷治療（NPWTi）に関する初の国際コンセンサスガイドライン1を公刊したと発表しました。本ガイドラインは、Journal of Plastic and Reconstructive Surgery誌12月号に掲載されています。...
View ArticleClik here to view.
Covidien Announces Transactions Aimed at Emerging Markets ‘Value Segment’
DUBLIN, Ireland Moving decisively to accelerate a key component of its emerging markets strategy, Covidien plc (NYSE:COV) has completed two transactions – one in Brazil and the other in China – that...
View ArticleClik here to view.
pSivida Corp. Reports First Orders for ILUVIEN® Shipped for U.K. National...
WATERTOWN, Mass. pSivida Corp. (NASDAQ: PSDV) (ASX: PVA), a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that its licensee...
View Article